Lifecore Biomedical, Inc. (LFCR) income statement
LFCRNasdaqPharmaceutical PreparationsFiscal year ends May 25
$6.39+0.02 (+0.31%)
Close on Nov 20, 2026Market cap $241.88MP/E –Yield –
Lifecore Biomedical, Inc. financial ratios
See a number that looks wrong?